Scientists work on a cure for type 1 diabetes
Sanford Health has begun the process of compiling research that could potentially put an end to type 1 diabetes.
Sanford Health has begun the process of compiling research that could potentially put an end to type 1 diabetes. If the study proves successful, type 1 diabetics may be able to buy this treatment at a Canadian online pharmacy.
According to the Centers for Disease Control and Prevention (CDC), type 1 diabetes has been known to affect children, but people of any age can get it. Currently, there is no known cure for this condition, and 5 percent of all diagnosed cases of diabetes are classified as type 1.
The study will monitor a sample of 54 diabetics, ages 11 to 45 years old, who will take either a combination of two medicines or placebos. In theory, the drugs should end the diabetics' dependency on daily insulin shots for survival.
"They're not the only ones [looking for a diabetes cure], but they're certainly on the cutting edge," said Jackie Casey, executive director of the MinnDakotas chapter of the Juvenile Diabetes Research Fund, quoted by the South Dakota newspaper Argus Leader.
She went on to say that, "If you're trying to bring a brand new drug to the marketplace, you have to go through lots of trials even to test the safety of the drug. They can completely skip that phase, because the drugs are already proven safe."
The drugs, sitagliptin and lansoprazole, have already been successfully proven to regenerate pancreatic cells in laboratory mice, according to the news source.